UK's MHRA Encourages Yellow Card Scheme Reporting

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:305 / 305
页数:1
相关论文
共 50 条
  • [42] Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK
    McLernon, David J.
    Bond, Christine M.
    Lee, Amanda J.
    Watson, Margaret C.
    Hannaford, Philip C.
    Fortnum, Heather
    Krska, Janet
    Anderson, Claire
    Murphy, Elizabeth
    Avery, Anthony
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (05) : 523 - 531
  • [43] Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology
    Daniel B Hawcutt
    Clare Pain
    Rachel Mulholland
    Lisa M Cann
    Gavin Cleary
    Michael W Beresford
    Eileen Baildam
    Pediatric Rheumatology, 9 (Suppl 1)
  • [44] Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator
    Deslandes, Paul N.
    Bracchi, Robert
    Jones, Karen
    Haines, Kath E.
    Carey, Emma
    Adams, Alana
    Walker, Jenna
    Thomas, Alison
    Routledge, Philip A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3829 - 3836
  • [45] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reactions 5 Years Since Launch
    Cumber, Sarah L.
    Heffer, Sarah J.
    Gandhi, Shelley
    Avery, Anthony J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S321 - S321
  • [46] Reporting unexpected benefit through the yellow card system
    Appleton, Anne
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [47] A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme
    Bracchi, RCG
    Houghton, J
    Woods, FJ
    Thomas, S
    Smail, SA
    Routledge, PA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (02) : 221 - 223
  • [48] ENDOCARDITIS PROPHYLAXIS & FATAL ANAPHYLACTIC REACTIONS ASSOCIATED WITH AMOXICILLIN REPORTED VIA THE YELLOW CARD SCHEME IN THE UK
    Lee, P.
    Shanson, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 : S43 - S43
  • [49] Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme
    O'Donovan, Bernadine
    Rodgers, Ruth M.
    Cox, Anthony R.
    Krska, Janet
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3434 - 3446
  • [50] Adverse effects of neuromuscular blocking agents based on yellow card reporting in the UK: are there differences between males and females?
    Light, KP
    Lovell, AT
    Butt, H
    Fauvel, NJ
    Holdcroft, A
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (03) : 151 - 160